Advertisement

Primary intraoperative transluminal angioplasty: a new approach to reduce the early failure of distal arteriovenous fistulas

Primary intraoperative transluminal angioplasty: a new approach to reduce the early failure of distal arteriovenous fistulas

J Vasc Access 2015; 16(3): 250 - 254

Article Type: TECHNIQUES IN VASCULAR ACCESS

Article Subject: Dialysis

DOI:10.5301/jva.5000327

Authors

Marcello Napoli, Maria L Lefons, Domenico Mangione, Cosimo Montagna, Elio Montagna, Anna M Montinaro, Caterina Pati, Giovanni Sandri, Efisio Sozzo, Salvatore Stefanizzi

Corresponding author

  • Marcello Napoli
  • Nephrology and Dialysis Unit
  • Via Roma 16573013 Galatina (LE)
  • Italymar.napoli@hotmail.com

Abstract

About 8 years ago, we approached an intraoperative transluminal angioplasty (ITA) performed during the arteriovenous fistula (AVF) creation, to treat arterial or venous stenosis diagnosed by a preliminary ultrasound examination. Objective of this study is to validate the efficacy of ITA.

Early failure (EF) and failure to mature (FTM) were evaluated in 69 AVFs with ITA created in 58 patients in the last 3 years. In the same period, 160 patients received 188 AVFs without ITA and were considered control group. Of the two groups, age, comorbid factors, sex, primary and secondary patency rate (PR) were also analysed.

The two groups were homogeneous for gender and age (70.4 + 11.1 years of ITA group vs. 66.3 + 14.4, p = 0.059). The incidence of diabetes, heart disease and peripheral artery disease was higher in the ITA group (43% vs. 17%, p<0.0001, 35% vs. 6%, p<0.0001 and 56% vs. 15%, p<0.0001, respectively). EF and FTM occurred in seven and eight cases in the ITA group and in 15 and 13 cases in the controls, respectively. Total failure occurred in 24% of ITA group and 14% of the controls (p = 0.2). The primary PR at 6, 12 and 24 months was 78%, 72% and 59% for ITA group and 85%, 78% and 78 % for control group (p<0.01). The secondary PR at 6, 12 and 24 months was 91%, 86% and 80% for ITA group and 95%, 95% and 92% for the controls (p<0.01).

Our ITA approach has allowed satisfactory results in patients at a high risk of AVF failure.

Article History

Disclosures

Financial support: The authors have no financial disclosures to make.
Conflict of interest: The authors have no conflict of interest.

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • Article price: Eur 36,00
  • You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.
  • If you are not a Subscriber you may:
  • Subscribe to this journal
  • Unlimited access to all our archives, 24 hour a day, every day of the week.

Authors

  • Napoli, Marcello [PubMed] [Google Scholar] , * Corresponding Author (Italymar.napoli@hotmail.com)
  • Lefons, Maria L [PubMed] [Google Scholar]
  • Mangione, Domenico [PubMed] [Google Scholar]
  • Montagna, Cosimo [PubMed] [Google Scholar]
  • Montagna, Elio [PubMed] [Google Scholar]
  • Montinaro, Anna M [PubMed] [Google Scholar]
  • Pati, Caterina [PubMed] [Google Scholar]
  • Sandri, Giovanni [PubMed] [Google Scholar]
  • Sozzo, Efisio [PubMed] [Google Scholar]
  • Stefanizzi, Salvatore [PubMed] [Google Scholar]

Affiliations

  • Nephrology and Dialysis Unit, S. Caterina Novella Hospital, Galatina - Italy

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

a
No supplementary material is available for this article.